Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > EV / EBITDA (ltm)

Ampio Pharmaceuticals EV / EBITDA (ltm) Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly EV / EBITDA (ltm) from 2019 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Ampio Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $288m a 87.68% increase of 253m year over year
  • Ampio Pharmaceuticals Price / Book for the quarter ending September 09, 2017 was 11.16 a 52.82% increase of 5.90 year over year
  • Ampio Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $280m a 88.15% increase of 247m year over year
View Chart On Koyfin